Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Back To over 16$

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Jan 13, 2020 5:26pm

60 Views

Post# 30548399

RE:RE:Back To over 16$

Eurnie, I read your informative post and I have no doubt you are don't understand what is posted below. Feel free to put me on ignore if your confused. I would appreciate it.

GunnerG wrote: Nope, back to $14.

NR today did not provide any progress on Ryplazim after two years. No mention at all about 4050 and Alstrom, where has it gone?

Talked of $130 million raised through equity and sale of assets. Dec 31, 2019 we had $61 million in cash. Not sure what the burn rate.

Production staff reductions in north america, top scientists let go, burned through almost half the cash, no progress announced on Ryplazim FDA required production changes, Alstrom and 4050 have gone silent, expanding clinical trials on numerous fronts (increased cash burn); not very convincing after a year+ of "new management".

Keep pumping though boys.

Lazer23 wrote: No volume, you want shares, you pay for them....7000 shares traded